AI assistant
JOHNSON & JOHNSON — Director's Dealing 2025
Nov 25, 2025
29750_dirs_2025-11-25_f3f6d7a3-448f-40c6-9669-677141d4cd48.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2025-11-21
Reporting Person: JOHNSON & JOHNSON (N/A)
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | Common Stock | S | 500 | $10.00 | Disposed | 4049398 | Indirect |
| 2025-11-24 | Common Stock | S | 2200 | $10.06 | Disposed | 4047198 | Indirect |
Footnotes
F1: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.